KKPCF Stock Price, Chart, Stats & News
Kaken Pharmaceutical Co. Ltd (KKPCF) is a dividend-paying stock with a current dividend yield of 9.66% as of Aug 14, 2026. It pays $2.51 per share over the trailing twelve months. Its dividend has grown at a 12.56% 5-year compound annual rate.
Dividend safety
KKPCF pays out about 2791% of earnings, leaving little safety margin.
KKPCF chart
About
Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a topical solution for onychomycosis; Artz, an anti-osteoarthritis medication; Seprafilm, an absorbable adhesion barrier used on damaged tissue; Fiblast, a spray designed for treating pressure and other skin ulcers; Regroth, a product aiding periodontal regeneration; and Hernicore, used for lumbar disc herniation.
Related lists
Similar securities
Based on sector and market capitalization
